| Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. | |
| | |
MedLine Citation:
|
PMID: 8288782 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Promising results have been reported from treatment with oral retinoids in patients with severe lichen sclerosus et atrophicus (LSA) of the vulva. OBJECTIVE: The aim of our study was to determine the efficacy of acitretin (20 to 30 mg/day) for 16 weeks in LSA. METHODS: Seventy-eight patients were enrolled into a multicenter, randomized, placebo-controlled, double-blind trial. The primary measure of efficacy was the "responder" rate based on the assessment of characteristic clinical features of LSA of the vulva (pruritus, burning, atrophy, hyperkeratosis, and secondary features such as erosions, ulcers, edema, or lichenification) and on the extent of the lesions. RESULTS: From the 46 patients eligible for efficacy analysis, a significantly higher number of responders was observed in the acitretin-treatment group (14 of 22 patients) as compared with the placebo-treatment group (6 of 24 patients). Typical retinoid adverse reactions were observed in all patients receiving active drug. CONCLUSION: Acitretin is effective in treating women with severe LSA of the vulva. |
| | |
Authors:
|
M T Bousema; U Romppanen; J M Geiger; M Baudin; K Vähä-Eskeli; J Vartiainen; S Vuopala |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of the American Academy of Dermatology Volume: 30 ISSN: 0190-9622 ISO Abbreviation: J. Am. Acad. Dermatol. Publication Date: 1994 Feb |
Date Detail:
|
Created Date: 1994-02-24 Completed Date: 1994-02-24 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7907132 Medline TA: J Am Acad Dermatol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 225-31 Citation Subset: IM |
Affiliation:
|
Department of Dermato-Venereology, Academic Hospital/Dijkigt, Rotterdam, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acitretin
/
adverse effects,
therapeutic use* Double-Blind Method Female Humans Lichenoid Eruptions / drug therapy* Middle Aged Vulvar Diseases / drug therapy* |
| Chemical | |
Reg. No./Substance:
|
55079-83-9/Acitretin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Lichen planus associated with neoplasia: a cell-mediated immune response to tumor antigens?
Next Document: The pathogenesis and clinical significance of xanthelasma palpebrarum.